View Full Paper

Owner Consent Verified
Policy Brief 4.8

Pharmacovigilance for Pharmaceutical Firms: Ethical Considerations | 2025–2028 Trends

12
Pages
IEEE
Style
~ 12–20 mins
Reading Time
Cold Chain Logistics InsurTech
Abstract

This policy brief investigates “Pharmacovigilance for Pharmaceutical Firms: Ethical Considerations | 2025–2028 Trends” using a propensity score matching. Through a human-centered lens, the analysis integrates multi-source data to derive an actionable roadmap for researchers and practitioners.

Download PDF Order Similar Paper Save

Pharmacovigilance for Pharmaceutical Firms: Ethical Considerations | 2025–2028 Trends

ABSTRACT
Pharmacovigilance for Pharmaceutical Firms: Ethical Considerations | 2025–2028 Trends is unpacked across themes: security, benefits, risks, and interoperability. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
26 Pages 4.2
Market Entry Strategy in Digital Identity for Esports Organizations: Evidence from Latin America
UX Food Systems Esports
View Paper
39 Pages 4.2
Innovation Diffusion in Digital Identity for Gen Z Shoppers: A topic modeling on open datasets
Cloud Logistics Cold Chain
View Paper
35 Pages 4.8
Climate Policy and Equity And Access among E-commerce Marketplaces — A Comparative Perspective
Esports RPA Green Finance
View Paper